American Diabetes Association Scientific Sessions

Healio brings you the highlights from the American Diabetes Association Scientific Sessions. Refer back to this page often for the latest news from ADA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Dulaglutide provides CKD benefits for those with type 2 diabetes, macroalbuminuria

June 13, 2019
SAN FRANCISCO — A 1.5 mg daily dose of dulaglutide may limit kidney function deterioration and the onset of end-stage renal disease for adults…
Meeting News

In monogenic diabetes research, a story of precision medicine at work

June 13, 2019
SAN FRANCISCO — The challenges facing the growing diabetes community today have never been greater, and researchers should look no further than…
Meeting News

DECLARE-TIMI 58: Dapagliflozin shows ‘robust’ potential for kidney disease prevention in type 2 diabetes

June 12, 2019
SAN FRANCISCO —Beyond improved cardiovascular outcomes, the SGLT2 inhibitor dapagliflozin may also offer adults with type 2 diabetes the…
Meeting News

Continued exposure to chronic hyperglycemia detrimental to developing brain, cognition

June 12, 2019
SAN FRANCISCO — Children with early-onset type 1 diabetes and worse glycemic control had slower growth in brain regions associated with mild…
Meeting News

Telehealth supports gestational diabetes education engagement

June 12, 2019
SAN FRANCISCO — Telehealth can provide an attractive alternative to in-person educational and psychosocial support for women with gestational…
Meeting News

CARMELINA: New linagliptin analyses demonstrate CV, kidney safety across all age, renal impairment groups

June 11, 2019
SAN FRANCISCO — In adults with type 2 diabetes, established cardiovascular disease and renal impairment, the DPP-IV inhibitor linagliptin did…
Meeting News

CAROLINA: Active-comparator study ‘vindicates’ glimepiride for CV safety

June 11, 2019
SAN FRANCISCO — A head-to-head comparison of the sulfonylurea glimepiride against the DPP-IV inhibitor linagliptin in a cohort of more than…
Meeting NewsVideo

VIDEO: New CREDENCE data demonstrates CV, renal benefit in primary prevention population

June 11, 2019
SAN FRANCISCO — In this video exclusive, Kenneth W. Mahaffey, MD, vice chair of clinical research in the department of medicine at Stanford…
Meeting News

Mixed results for sitagliptin, liraglutide for perioperative management of hyperglycemia during cardiac surgery

June 11, 2019
SAN FRANCISCO — Two studies presented at the American Diabetes Association Scientific Sessions yield mixed results for the use of approved…
Meeting News

CGM relieves burden, improves HbA1c for teens

June 10, 2019
SAN FRANCISCO — Using a continuous glucose monitor can lead to improved HbA1c and superior satisfaction for adolescents and young adults with…